S&P 500   3,232.26 (-2.63%)
DOW   26,722.44 (-3.38%)
QQQ   261.72 (-1.93%)
AAPL   105.27 (-1.47%)
MSFT   197.46 (-1.46%)
FB   245.45 (-2.80%)
GOOGL   1,408.72 (-2.92%)
AMZN   2,890.95 (-2.16%)
NVDA   481.20 (-1.31%)
TSLA   436.22 (-1.34%)
BABA   267.12 (-1.94%)
CGC   15.55 (-4.95%)
MU   48.44 (-4.53%)
GE   6.30 (-8.43%)
AMD   75.32 (+0.52%)
T   28.45 (-1.66%)
F   6.86 (-5.12%)
ACB   6.25 (-4.29%)
GILD   63.48 (-2.41%)
NFLX   470.96 (+0.21%)
DIS   123.67 (-3.86%)
BAC   24.14 (-4.24%)
BA   155.49 (-3.51%)
S&P 500   3,232.26 (-2.63%)
DOW   26,722.44 (-3.38%)
QQQ   261.72 (-1.93%)
AAPL   105.27 (-1.47%)
MSFT   197.46 (-1.46%)
FB   245.45 (-2.80%)
GOOGL   1,408.72 (-2.92%)
AMZN   2,890.95 (-2.16%)
NVDA   481.20 (-1.31%)
TSLA   436.22 (-1.34%)
BABA   267.12 (-1.94%)
CGC   15.55 (-4.95%)
MU   48.44 (-4.53%)
GE   6.30 (-8.43%)
AMD   75.32 (+0.52%)
T   28.45 (-1.66%)
F   6.86 (-5.12%)
ACB   6.25 (-4.29%)
GILD   63.48 (-2.41%)
NFLX   470.96 (+0.21%)
DIS   123.67 (-3.86%)
BAC   24.14 (-4.24%)
BA   155.49 (-3.51%)
S&P 500   3,232.26 (-2.63%)
DOW   26,722.44 (-3.38%)
QQQ   261.72 (-1.93%)
AAPL   105.27 (-1.47%)
MSFT   197.46 (-1.46%)
FB   245.45 (-2.80%)
GOOGL   1,408.72 (-2.92%)
AMZN   2,890.95 (-2.16%)
NVDA   481.20 (-1.31%)
TSLA   436.22 (-1.34%)
BABA   267.12 (-1.94%)
CGC   15.55 (-4.95%)
MU   48.44 (-4.53%)
GE   6.30 (-8.43%)
AMD   75.32 (+0.52%)
T   28.45 (-1.66%)
F   6.86 (-5.12%)
ACB   6.25 (-4.29%)
GILD   63.48 (-2.41%)
NFLX   470.96 (+0.21%)
DIS   123.67 (-3.86%)
BAC   24.14 (-4.24%)
BA   155.49 (-3.51%)
S&P 500   3,232.26 (-2.63%)
DOW   26,722.44 (-3.38%)
QQQ   261.72 (-1.93%)
AAPL   105.27 (-1.47%)
MSFT   197.46 (-1.46%)
FB   245.45 (-2.80%)
GOOGL   1,408.72 (-2.92%)
AMZN   2,890.95 (-2.16%)
NVDA   481.20 (-1.31%)
TSLA   436.22 (-1.34%)
BABA   267.12 (-1.94%)
CGC   15.55 (-4.95%)
MU   48.44 (-4.53%)
GE   6.30 (-8.43%)
AMD   75.32 (+0.52%)
T   28.45 (-1.66%)
F   6.86 (-5.12%)
ACB   6.25 (-4.29%)
GILD   63.48 (-2.41%)
NFLX   470.96 (+0.21%)
DIS   123.67 (-3.86%)
BAC   24.14 (-4.24%)
BA   155.49 (-3.51%)
Log in
NASDAQ:DNLI

Denali Therapeutics Price Target, Predictions & Analyst Ratings

$37.51
-1.10 (-2.85 %)
(As of 09/21/2020 11:22 AM ET)
Add
Compare
Today's Range
$37.45
Now: $37.51
$38.46
50-Day Range
$23.24
MA: $31.10
$38.84
52-Week Range
$12.39
Now: $37.51
$39.22
Volume8,749 shs
Average Volume657,776 shs
Market Capitalization$3.98 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.91

Analyst Ratings

Denali Therapeutics (NASDAQ:DNLI) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for Denali Therapeutics in the last 12 months. Their average twelve-month price target is $33.70, predicting that the stock has a possible downside of 10.16%. The high price target for DNLI is $45.00 and the low price target for DNLI is $20.00. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
DNLI Consensus Rating: BuyBuyBuyBuy
DNLI Consensus Rating Score: 2.822.802.822.80
DNLI Analyst Ratings: 0 Sell Rating(s)
2 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
DNLI Consensus Price Target: $33.70$31.67$29.80$29.67
DNLI Price Target Upside: 10.16% downside1.29% downside27.19% upside74.10% upside

Denali Therapeutics (NASDAQ:DNLI) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Denali Therapeutics (NASDAQ:DNLI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/14/2020JPMorgan Chase & Co.Initiated CoverageOverweight$35.00High
8/24/2020Morgan StanleyBoost Price TargetOverweight$28.00 ➝ $45.00Medium
8/20/2020HC WainwrightReiterated RatingBuy$28.00 ➝ $45.00Medium
8/10/2020WedbushReiterated RatingOutperformMedium
5/13/2020NomuraReiterated RatingBuy$35.00Low
3/18/2020Cantor FitzgeraldReiterated RatingNeutralMedium
3/13/2020Evercore ISIUpgradeIn-Line ➝ Outperform$20.00High
3/9/2020Nomura SecuritiesReiterated RatingBuy$35.00Low
2/24/2020Jefferies Financial GroupInitiated CoverageBuy$35.00High
2/18/2020Stifel NicolausInitiated CoverageHold$26.00Low
1/26/2020Goldman Sachs GroupUpgradeNeutral ➝ Buy$20.00 ➝ $37.00High
8/9/2019BTIG ResearchInitiated CoverageBuy ➝ Buy$30.00High
11/12/2018Janney Montgomery ScottInitiated CoverageBuy ➝ Buy$26.00Low
(Data available from 9/21/2018 forward)
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.